Dichlorphenamide 50 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg
Reference Brands: Keveyis (USA/EU)
Category: Neurology
Dichlorphenamide is a Neurology product available as Tablets in strengths 50 mg. It corresponds to the reference brand Keveyis (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Dichlorphenamide, also known as diclofenamide, is a sulfonamide-based carbonic anhydrase inhibitor belonging to the meta-disulfamoylbenzene class. It is classified as a first-generation carbonic anhydrase inhibitor and has a long history of clinical use across multiple therapeutic areas. The drug works by inhibiting carbonic anhydrase enzymes, leading to alterations in electrolyte balance and cellular excitability.
Historically, dichlorphenamide was approved in the United States in 1958 under the brand name Daranide for the treatment of glaucoma, including acute angle-closure glaucoma. Over time, it was also found to be effective in certain cases of therapy-resistant epilepsy. Further clinical research later established its role in neuromuscular disorders.
In 2015, dichlorphenamide received approval in the United States as an orphan drug under the brand name Keveyis for the treatment of primary periodic paralysis, including both hypokalemic and hyperkalemic forms. By stabilizing muscle membrane excitability, it helps reduce the frequency and severity of paralytic attacks. Due to its pharmacological activity, dichlorphenamide is prescribed under specialist supervision with appropriate clinical monitoring.
Dichlorphenamide — third party manufacturing & bulk supply
Dichlorphenamide 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dichlorphenamide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dichlorphenamide →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dichlorphenamide is used for the treatment of primary periodic paralysis, including hyperkalemic periodic paralysis, hypokalemic periodic paralysis, and related variants, in adult and pediatric patients.
Dichlorphenamide is a synthetic small-molecule carbonic anhydrase inhibitor formulated for oral administration.
The trade name of dichlorphenamide is Keveyis.
Keveyis is developed and marketed by Strongbridge Biopharma, which is now part of Xeris Biopharma.
The complete generic name is dichlorphenamide.
The approved brand name is Keveyis.
Dichlorphenamide is manufactured in GMP-approved facilities in the USA and other regulated pharmaceutical manufacturing regions, depending on the authorized manufacturer and supply chain.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View Details
Quick Response Guaranteed | Verified Suppliers
